Australian Pharmaceutical Industries v Egan

Link copied
Case Copied 13 min read
CITATION: Australian Pharmaceutical Industries v Egan [2010] NSWSC 203
HEARING DATE(S): 26/2/10
JURISDICTION: Equity Division
Commercial List
JUDGMENT OF: McDougall J at 1
EX TEMPORE JUDGMENT DATE: 26 February 2010
DECISION: Leave to withdraw admission not granted
CATCHWORDS: PROCEDURE - admissions - application for leave by defendant to withdraw admission made in cross-examination - whether admission made inadvertently or without consideration of material matters - where relevant material had been put before defendant and defendant was questioned fairly about it - whether admission reflected true state of affairs.
CATEGORY: Procedural and other rulings
CASES CITED: Hill End Gold Ltd v First Tiffany Resources Corp [2008] NSWSC 866
Stafford v Kekatos (No 2) [2008] NSWSC 1044
PARTIES: Australian Pharmaceutical Industries Limited (Plaintiff)
Elizabeth Anne Egan (Defendant)
FILE NUMBER(S): SC 2009/298774
COUNSEL: M Condon (Plaintiff)
S O'Brien (Defendant)
SOLICITORS: Holman Webb Lawyers (Plaintiff)
McDonald Johnson Lawyers (Defendant)


IN THE SUPREME COURT
OF NEW SOUTH WALES
EQUITY DIVISION
COMMERCIAL LIST

McDOUGALL J

26 February 2010

50167/09 AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED v EGAN

JUDGMENT

1 HIS HONOUR: Two notices of motion were referred to me today for hearing in these proceedings. In point of time, the first notice of motion was the plaintiff’s, filed on 2 December 2009, in which it sought among other things, orders that the commercial response be struck out and judgment.

2 That notice of motion has been amended by an amended notice of motion filed in Court today in which the plaintiff seeks leave to file an amended list statement (that leave has been given) and, among other things, judgment for the amount as claimed on a summary basis.

3 The other notice of motion is the defendant’s notice of motion in which she seeks leave to withdraw an admission made by her in cross-examination on 14 December 2009.

4 The admission identified in the defendant’s notice of motion is “that the plaintiff has given the defendant credit for an amount of $935,000 as shown in” a certain document. That was put to the defendant in cross-examination on an earlier occasion. I was informed that the two notices of motion would take between them two hours of hearing time: an accurate assessment but for a matter to which I shall refer in due course.

5 Accordingly, that estimate being at what I might call the outer end of time available on a Friday (and just below the limit by reference to which special fixtures should be set) I proceeded with the hearing of the two motions. Logically, the defendant’s notice of motion was the first dealt with.

6 The admission in question was made in cross-examination on 14 December 2009, in the course of the hearing the unamended notice of motion of the plaintiff. It is desirable to know a little of the background to these proceedings.

7 The plaintiff supplies, among other things, pharmaceutical goods to its customers who are pharmacists carrying on business throughout New South Wales and, no doubt, elsewhere. The defendant has at all material…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Australian Pharmaceutical Industries v Egan and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2010] NSWSC 203
Decision Date

CaseChat Overview and Summary

The case of Australian Pharmaceutical Industries v Egan involves a dispute concerning admissions made during cross-examination and the subsequent application by the defendant to withdraw those admissions. The matter was heard in the Supreme Court of New South Wales. The plaintiff, Australian Pharmaceutical Industries, sought to enforce a contractual obligation against the defendant, Egan, who had made certain admissions during the cross-examination that were central to the plaintiff's case. Egan applied for leave to withdraw these admissions, arguing that they were made inadvertently or without consideration of relevant material.

The primary legal issue before the court was whether the defendant's admissions could be withdrawn based on the contention that they were made without proper consideration or inadvertently. The court had to determine whether the defendant had been fairly questioned about the relevant material and whether the admissions accurately reflected the true state of affairs. The court examined the procedural fairness of the cross-examination and the defendant's awareness of the material at the time of making the admissions.

The court found that the defendant had been questioned fairly and that all relevant material had been brought to their attention during the cross-examination. The admissions made by the defendant were considered to accurately reflect the true state of affairs. Consequently, the court denied the application for leave to withdraw the admissions. The reasoning of the court was that the defendant had ample opportunity to consider the material and had made the admissions knowingly and with full awareness of the circumstances. The court concluded that the admissions stood as evidence and could not be withdrawn without good reason.

The final orders of the court were that the defendant's application to withdraw the admissions made during cross-examination was dismissed. The admissions would remain as part of the evidence in the case.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.